Table 1

Basic characteristics of study subjects (n= 513)
Variable Mean Male (n= 266) Female (n= 247) P
Age (years) 59.1 ± 7.0 59.3 ± 6.9* 58.8 ± 7.0 0.226
Hypertension, n (%) 146 (28.5) 85 (32.0) 61(24.7) 0.069
Diabetes, n (%) 49 (9.6) 28 (10.5) 21 (8.5) 0.436
Waist circumference (cm) 80.0 ± 8.6 84.0 ± 7.6 75.6 ± 7.3 < 0.001
Central obesity, n (%) 114 (22.2) 50 (18.8) 64 (25.9) 0.053
Hip circumference (cm) 92.5 ± 5.4 92.4 ± 5.3 92.6 ± 5.4 0.692
Waist-to-hip ratio (%) 86.4 ± 7.2 91.7 ± 5.4 81.7 ± 5.9 < 0.001
WHtR (%) 49.8 ± 4.9 50.6 ± 4.5 48.9 ± 5.1 < 0.001
BMI (kg/m2) 24.2 ± 3.0 24.5 ± 2.7 23.9 ± 3.0 0.005
Body adiposity index 27.6 ± 3.9 25.2 ± 2.7 30.1 ± 3.4 < 0.001
Systolic blood pressure (mmHg) 130 ± 19 128 ± 18 132 ± 20 0.007
Diastolic blood pressure (mmHg) 76 ± 12 79 ± 11 72 ± 12 < 0.001
Total cholesterol (mM) 5.09 ± 0.92 4.97 ± 0.96 5.21 ± 0.85 0.001
Total cholesterol ≥ 6.22 mM, n (%) 52 (10.1) 21 (7.9) 31 (12.6) 0.081
HDL-C (mM) 1.40 ± 0.39 1.28 ± 0.36 1.52 ± 0.39 < 0.001
HDL-C < 0.9 mM in men or < 1.03 mM in women, n (%) 128 (25.0) 54 (20.3) 74 (30.0) 0.012
Triglyceride (mM) 1.33 ± 0.78 1.42 ± 0.85 1.22 ± 0.70 0.002
Triglyceride ≥ 1.70 mM, n (%) 121 (23.6) 70 (26.3) 51 (20.6) 0.131
Fasting glucose (mM) 5.25 ± 1.08 5.29 ± 1.10 5.19 ± 1.05 0.127
Fasting glucose ≥ 5.6 mM, n (%) 95 (18.5) 56 (21.1) 39 (15.8) 0.125
MS-TW, n (%) 105 (20.5) 52 (19.5) 53 (21.5) 0.592
LAP 25.9 ± 21.6 23.0 ± 23.2 28.6 ± 19.3 0.001

*Values are mean ± standard deviation except otherwise denoted.

Central obesity: waist circumference ≥ 90 cm in males and ≥ 80 cm in females.

Body adiposity index: (hip circumference/height1.5) − 18.

Hypertension: subjects with a history of hypertension or using antihypertensive medications.

HDL-C high-density lipoprotein cholesterol, MS-TW: metabolic syndrome criteria for Taiwanese, WHtR waist-to-height ratio, BMI body mass index, LAP lipid accumulation product.

Chiang and Koo

Chiang and Koo BMC Cardiovascular Disorders 2012 12:78   doi:10.1186/1471-2261-12-78

Open Data